Current position:Home >Product >
6H-Pyrido[2,3-b][1,4]benzodiazepin-6-one, 9-chloro-5,11-dihydro-5-propyl-
6H-Pyrido[2,3-b][1,4]benzodiazepin-6-one, 9-chloro-5,11-dihydro-5-propyl-(4929-23-1)
- Name: 6H-Pyrido[2,3-b][1,4]benzodiazepin-6-one, 9-chloro-5,11-dihydro-5-propyl-
- Synonyms:6H-Pyrido[2,3-b][1,4]benzodiazepin-6-one, 9-chloro-5,11-dihydro-5-propyl-;9-Chloro-5,11-dihydro-5-propyl-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one;BI-0115;inhibit,BI-0115,LOX-1,atherosclerosis,BI0115,BI 0115,oxLDL binding,Inhibitor;14-chloro-9-propyl-2,4,9-triazatricyclo[9.4.0.03,?]pentadeca-1(11),3(8),4,6,12,14-hexaen-10-one;9-Chloro-5-propyl-5,11-dihydro-6H-benzo[e]pyrido[3,2-b][1,4]diazepin-6-one
- Molecular Formula:C15H14ClN3O
- Molecular Weight:287.74
- CAS Registry Number:4929-23-1
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 491867-79-9/N-(6-Acetylbenzo[3,4-d]1,3-dioxolen-5-yl)-2-(4-methylpiperazinyl)ethanamide
- 491867-81-3/N-(6-Acetylbenzo[d]1,3-dioxolen-5-yl)-2-(4-phenylpiperazinyl)ethanamide
- 491867-83-5/N-Benzo[d]1,3-dioxolen-5-yl-2-(4-phenylpiperazinyl)ethanamide
- 491868-03-2/1H-1,2,3-Triazole-4-carboxylic acid, 1-[(4-fluorophenyl)methyl]-, ethyl ester
- 491873-61-1/2-(4-chlorophenyl)-5-[(4H-1,2,4-triazol-3-ylsulfanyl)methyl]-1,3,4-oxadiazole
- 492425-29-3/2-amino-4-(1-ethyl-5-methylpyrazol-4-yl)-7,7-dimethyl-5-oxo-6,8-dihydro-4H-chromene-3-carbonitrile
- 492425-33-9/2-amino-4-(1-ethyl-3-methyl-1H-pyrazol-4-yl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile
- 492425-48-6/4H-1-Benzopyran-3-carbonitrile, 2-amino-4-(1,5-dimethyl-1H-pyrazol-4-yl)-5,6,7,8-tetrahydro-7,7-dimethyl-5-oxo-
- 492426-93-4/NA
- 492426-95-6/2-amino-5-oxo-4-(1,3,5-trimethyl-1H-pyrazol-4-yl)-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile
- 492428-96-3/6-(Difluoromethyl)-2-[(5-formyl-2-methoxybenzyl)thio]-4-methylnicotinonitrile
- 492434-20-5/7-(Difluoromethyl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine-3-carboxylic acid
- 492434-69-2/(2R,3S)-1-aMino-4-Methyl-2-(naphthalen-2-yl)pentan-3-ol
- 492434-74-9/2-Naphthaleneethanol, β-[(dimethylamino)methyl]-α-(1-methylethyl)-, (αS,βR)-
- 492442-13-4/2-(4-sec-Butylphenyl)-6-methylquinoline-4-carboxylic acid
- 492442-28-1/2-(5-Chlorothien-2-yl)-6-methylquinoline-4-carboxylic acid
- 492448-66-5/2-(4-Chlorophenyl)-3,8-dimethylquinoline-4-carboxylic acid
- 492457-03-1/6-amino-4-(1-ethyl-3,5-dimethyl-1H-pyrazol-4-yl)-3-methyl-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile
- 4928-49-8/2,5-Pyridinediamine, N2-[3-(dimethylamino)propyl]-
- 4929-23-1/6H-Pyrido[2,3-b][1,4]benzodiazepin-6-one, 9-chloro-5,11-dihydro-5-propyl-
- 492990-36-0/Bone morphogenetic protein receptor type-1A
- 492994-20-4/Acetic acid, 2-diazo-, ethyl ester, homopolymer
- 492997-55-4/2-(3,4-Dimethoxyphenyl)-6,8-dimethylquinoline-4-carboxylic acid
- 492997-60-1/2-(3-Methoxyphenyl)-6,8-dimethylquinoline-4-carboxylic acid
- 492998-36-4/N-(3,5-Dichlorophenyl)-2-[(2-ethylphenyl)(methylsulfonyl)amino]acetamide
- 492998-53-5/[2H4]-Isatin
- 493002-01-0/2-(N-(3,5-Dichlorophenyl)methylsulfonamido)-N-isobutylacetamide
- 493002-81-6/N-(2,6-dimethylphenyl)-6-methoxy-2-oxochromene-3-carboxamide
- 493003-07-9/4-(5-{[(2,4-dichlorophenyl)methyl]sulfanyl}-1,3,4-oxadiazol-2-yl)phenol
- 493003-17-1/2-[[5-(2-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-(3-chloro-2-methylphenyl)acetamide